Reduced mitochondrial pyruvate carrier expression in hearts with heart failure and reduced ejection fraction patients: ischemic vs. non-ischemic origin
Introduction and objectivesMitochondrial pyruvate carrier (MPC) mediates the entry of pyruvate into mitochondria, determining whether pyruvate is incorporated into the Krebs cycle or metabolized in the cytosol. In heart failure (HF), a large amount of pyruvate is metabolized to lactate in the cytoso...
Main Authors: | Paula Lopez-Vazquez, Mariana Fernandez-Caggiano, Eduardo Barge-Caballero, Gonzalo Barge-Caballero, David Couto-Mallon, Zulaika Grille-Cancela, Paula Blanco-Canosa, Maria J. Paniagua-Martin, Daniel Enriquez-Vazquez, Jose M. Vazquez-Rodriguez, Nieves Domenech, Maria G. Crespo-Leiro |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-03-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2024.1349417/full |
Similar Items
-
Determinants of maximal oxygen uptake in patients with heart failure
by: Javier Roibal Pravio, et al.
Published: (2021-06-01) -
Mitochondrial haplogroups H and J: risk and protective factors for ischemic cardiomyopathy.
by: Mariana Fernández-Caggiano, et al.
Published: (2012-01-01) -
Light-Chain Cardiac Amyloidosis
by: Gonzalo Barge-Caballero, MD, et al.
Published: (2019-10-01) -
Sex differences in the impact of frailty in elderly outpatients with heart failure
by: Pablo Díez-Villanueva, et al.
Published: (2022-09-01) -
Ischemic Cardiomyopathy versus Non-Ischemic Dilated Cardiomyopathy in Patients with Reduced Ejection Fraction— Clinical Characteristics and Prognosis Depending on Heart Failure Etiology (Data from European Society of Cardiology Heart Failure Registries)
by: Agata Tymińska, et al.
Published: (2022-02-01)